Inhibition of Human Platelet Aggregation and Cytoplasmic Calcium Response by Calcium Antagonists: Studies with Aequorin and Quin2
Inhibition of Human Platelet Aggregation and Cytoplasmic Calcium Response by Calcium Antagonists: Studies with Aequorin and Quin2
复制标题
钙拮抗剂抑制人血小板聚集和细胞质钙反应:水母发光蛋白和 Quin2 的研究
DOI:
10.1161/01.res.59.1.39
复制
发表时间:
1986
影响因子:
20.1
通讯作者:
E. Salzman
中科院分区:
文献类型:
--
作者:
J. Ware;P. Johnson;Marianne Smith;E. Salzman
Calcium antagonists inhibit platelet aggregation, but whether this action is due to inhibition of the effect of agonists on cytoplasmic ionized calcium concentration is unknown. We studied this problem by loading gel-filtered platelets with either quin2 or aequorin and stimulating them with epinephrine, arachidonate, thrombin, the calcium ionophore A23187, l-oleoyl-2-acetyl glycerol, or adenosine diphosphate in media with or without extracellular calcium. In response to all of these agonists, aequorin indicated an increase in cytoplasmic calcium that accompanied or preceded platelet aggregation. In calcium-containing media, verapamil, nifedipine, and diltiazem inhibited these effects in a concentration-dependent fashion, except for those produced by thrombin and A23187. Removal of extracellular calcium with EGTA reduced the calcium response to arachidonate, adenosine diphosphate, and l-oleoyl-2-acetyl glycerol, and the calcium response and aggregation were further inhibited by the calcium antagonists. In general, strong inhibition of the aequorin cytoplasmic calcium signal by approximately 100 μM concentrations of nifedipine, verapamil, and diltiazem was correlated with inhibition of platelet aggregation, but high concentrations of the inhibitors were required. Since inhibition by the calcium antagonists of the cytoplasmic calcium response and aggregation exceeded the effect of simple removal of extracellular calcium, these drugs may affect internal redistribution of calcium in human platelets.
影响因子:
20.1
作者:
Motulsky,HJ;Snavely,MD;Hughes,RJ;Insel,PA
通讯作者:
Insel,PA